Donna A. Culton

2.2k total citations
57 papers, 862 citations indexed

About

Donna A. Culton is a scholar working on Pathology and Forensic Medicine, Rheumatology and Genetics. According to data from OpenAlex, Donna A. Culton has authored 57 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pathology and Forensic Medicine, 24 papers in Rheumatology and 22 papers in Genetics. Recurrent topics in Donna A. Culton's work include Autoimmune Bullous Skin Diseases (37 papers), Urticaria and Related Conditions (22 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (22 papers). Donna A. Culton is often cited by papers focused on Autoimmune Bullous Skin Diseases (37 papers), Urticaria and Related Conditions (22 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (22 papers). Donna A. Culton collaborates with scholars based in United States, China and Brazil. Donna A. Culton's co-authors include Luis A. Díaz, Stephen H. Clarke, Shannon M. Pop, Roland Tisch, Carmen P. Wong, Zhi Liu, Ning Li, Ye Qian, Russell P. Hall and Evandro A. Rivitti and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Donna A. Culton

49 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna A. Culton United States 16 390 303 294 257 125 57 862
Chika Ohata Japan 18 529 1.4× 429 1.4× 172 0.6× 350 1.4× 65 0.5× 75 924
Shogo Banno Japan 19 319 0.8× 182 0.6× 221 0.8× 192 0.7× 34 0.3× 91 1.1k
Takekuni Nakama Japan 17 444 1.1× 328 1.1× 154 0.5× 310 1.2× 25 0.2× 80 842
Conleth A. Egan United States 19 530 1.4× 445 1.5× 88 0.3× 297 1.2× 61 0.5× 51 958
Barbara Giomi Italy 15 323 0.8× 498 1.6× 224 0.8× 226 0.9× 29 0.2× 36 740
Hossein Mortazavi Iran 20 537 1.4× 366 1.2× 105 0.4× 324 1.3× 28 0.2× 60 993
Kumutnart Chanprapaph Thailand 19 263 0.7× 276 0.9× 143 0.5× 59 0.2× 50 0.4× 73 941
Uma Thanarajasingam United States 14 108 0.3× 79 0.3× 232 0.8× 151 0.6× 121 1.0× 32 781
Matthieu Mahévas France 14 143 0.4× 110 0.4× 259 0.9× 114 0.4× 46 0.4× 38 810
A D'agata Italy 16 212 0.5× 325 1.1× 147 0.5× 166 0.6× 22 0.2× 31 662

Countries citing papers authored by Donna A. Culton

Since Specialization
Citations

This map shows the geographic impact of Donna A. Culton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna A. Culton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna A. Culton more than expected).

Fields of papers citing papers by Donna A. Culton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna A. Culton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna A. Culton. The network helps show where Donna A. Culton may publish in the future.

Co-authorship network of co-authors of Donna A. Culton

This figure shows the co-authorship network connecting the top 25 collaborators of Donna A. Culton. A scholar is included among the top collaborators of Donna A. Culton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna A. Culton. Donna A. Culton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anandarajah, Allen, Saira Z. Sheikh, Sam Lim, et al.. (2025). A Provider‐Based Approach to Address Racial Disparities in Lupus Clinical Trial Participation. UNC Libraries.
2.
Culton, Donna A., et al.. (2024). Oral Diseases in the Geriatric Population. Current Geriatrics Reports. 13(3). 104–114. 1 indexed citations
3.
Uzun, Soner, Aslı Bilgiç Temel, Baoqi Yang, et al.. (2024). Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid‐induced myopathy. Journal of the European Academy of Dermatology and Venereology. 39(2). 340–349.
4.
Temel, Aslı Bilgiç, Donna A. Culton, Maryam Daneshpazhooh, et al.. (2024). Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid‐induced myopathy. UNC Libraries.
6.
Googe, Paul B., et al.. (2024). Treatment of Pembrolizumab-Induced Mucocutaneous Lichen Planus With Metronidazole. JAMA Dermatology. 160(11). 1251–1251.
7.
Culton, Donna A., et al.. (2024). Effectiveness and tolerability of systemic therapies in oral lichen planus: A retrospective cohort study. JAAD International. 15. 136–138. 2 indexed citations
8.
Googe, Paul B., et al.. (2024). Treatment of immune checkpoint inhibitor-induced bullous pemphigoid with methotrexate. JAAD Case Reports. 54. 31–36. 2 indexed citations
9.
Chen, Jinbo, Ning Li, Li Wan, et al.. (2023). The Eotaxin-1/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid. The Journal of Immunology. 211(8). 1216–1223. 4 indexed citations
10.
Culton, Donna A., et al.. (2023). 42047 Mycophenolate Mofetil for Treatment of Oral Lichen Planus – Retrospective Cohort Study. Journal of the American Academy of Dermatology. 89(3). AB67–AB67.
11.
Culton, Donna A., et al.. (2023). What is Lichen planus pemphigoides? A highlight of three cases with discussion of differential diagnosis and suggestion of simple classification guidelines. Anais Brasileiros de Dermatologia. 98(3). 378–381. 1 indexed citations
12.
Chen, Jinbo, Ning Li, Donna A. Culton, et al.. (2022). 050 Eotaxin-1 and matrix metalloproteinase-9 are critical in anti-BP180 IgE-induced experimental bullous pemphigoid. Journal of Investigative Dermatology. 142(8). S9–S9. 1 indexed citations
13.
Werth, Victoria P., Donna A. Culton, Josef Symon S. Concha, et al.. (2021). Safety, Tolerability, and Activity of ALXN1830 Targeting the Neonatal Fc Receptor in Chronic Pemphigus. Journal of Investigative Dermatology. 141(12). 2858–2865.e4. 32 indexed citations
14.
Culton, Donna A., et al.. (2019). A case of late-onset neutropenia secondary to rituximab in a patient with mucous membrane pemphigoid. JAAD Case Reports. 5(8). 715–719. 3 indexed citations
15.
Roth, Aleeza J., Phillip Prisayanh, Brenda Temple, et al.. (2018). Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope. Journal of Autoimmunity. 89. 171–185. 17 indexed citations
16.
Werth, V., et al.. (2018). 538 FcRn blockade with SYNT001 for the treatment of pemphigus. Journal of Investigative Dermatology. 138(5). S92–S92. 11 indexed citations
17.
Lin, Lan, Donna A. Culton, Ning Li, et al.. (2017). Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid. Journal of Investigative Dermatology. 138(5). 1032–1043. 70 indexed citations
18.
Qian, Ye, et al.. (2016). Non-infectious environmental antigens as a trigger for the initiation of an autoimmune skin disease. Autoimmunity Reviews. 15(9). 923–930. 19 indexed citations
19.
Culton, Donna A., Ye Qian, Ning Li, et al.. (2008). Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: A paradigm of human autoimmunity. Journal of Autoimmunity. 31(4). 311–324. 61 indexed citations
20.
Culton, Donna A., et al.. (2006). Early Preplasma Cells Define a Tolerance Checkpoint for Autoreactive B Cells. The Journal of Immunology. 176(2). 790–802. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026